Literature DB >> 8520030

Abl tyrosine protein kinase.

P Laneuville1.   

Abstract

Mammalian c-Abl belongs to an evolutionary conserved family of non-receptor tyrosine kinases. It is distributed both in the cytoplasm in association with F-actin, and in the nucleus where it binds chromatin. The normal function of c-Abl is poorly understood. Nevertheless, there has been rapid progress in the characterization of the structural features, signal transduction pathways, substrates and ligands involved in the action of c-Abl and Abl-derived oncogenes. These developments suggest that several mechanisms co-operate to allow regulation of normal cell growth by c-Abl and induction of leukemias by Bcr-abl.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520030     DOI: 10.1006/smim.1995.0030

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  8 in total

1.  The c-Abl expression in uterine epithelium during the mouse estrus cycle.

Authors:  A Yaba Ucar; U A Kayisli; N Demir
Journal:  J Mol Histol       Date:  2011-12-06       Impact factor: 2.611

2.  The Abelson tyrosine kinase (c-Abl) expression on the mouse uterus and placenta during gestational period.

Authors:  Aylin Yaba; Umit Ali Kayisli; Joshua Johnson; Ramazan Demir; Necdet Demir
Journal:  J Mol Histol       Date:  2011-01-20       Impact factor: 2.611

3.  Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway.

Authors:  Z Dai; R C Quackenbush; K D Courtney; M Grove; D Cortez; G W Reuther; A M Pendergast
Journal:  Genes Dev       Date:  1998-05-15       Impact factor: 11.361

4.  p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.

Authors:  X Zou; F Cong; M Coutts; G Cattoretti; S P Goff; K Calame
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

5.  Protein binding and signaling properties of RIN1 suggest a unique effector function.

Authors:  L Han; D Wong; A Dhaka; D Afar; M White; W Xie; H Herschman; O Witte; J Colicelli
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines.

Authors:  M Dorsch; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

7.  Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals.

Authors:  Alyson Swimm; Bettina Bommarius; Yue Li; David Cheng; Patrick Reeves; Melanie Sherman; Darren Veach; William Bornmann; Daniel Kalman
Journal:  Mol Biol Cell       Date:  2004-05-21       Impact factor: 4.138

8.  Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia.

Authors:  Gunhild Keller-von Amsberg; Steffen Koschmieder
Journal:  Onco Targets Ther       Date:  2013-03-04       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.